Your browser doesn't support javascript.
loading
The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis.
Jarr, Kai-Uwe; Ye, Jianqin; Kojima, Yoko; Ye, Zhongde; Gao, Hua; Schmid, Sofie; Luo, Lingfeng; Baylis, Richard A; Lotfi, Mozhgan; Lopez, Nicolas; Eberhard, Anne V; Smith, Bryan Ronain; Weissman, Irving L; Maegdefessel, Lars; Leeper, Nicholas J.
Afiliación
  • Jarr KU; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Ye J; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Kojima Y; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Ye Z; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Gao H; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Schmid S; Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Luo L; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Baylis RA; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Lotfi M; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Lopez N; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Eberhard AV; Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, California, United States of America.
  • Smith BR; Department of Biomedical Engineering, Michigan State University, East Lansing, Michigan, United States of America.
  • Weissman IL; Institute for Quantitative Health Science and Engineering, East Lansing, Michigan, United States of America.
  • Maegdefessel L; Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, United States of America.
  • Leeper NJ; Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Nat Cardiovasc Res ; 1(3): 253-262, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35990913
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cardiovasc Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cardiovasc Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos